In STEP-1, cholelithiasis (gallstones) occurred in 2.6% of the semaglutide group versus 1.2% on placebo, and cholecystitis occurred in 0.8% versus 0.4% [1]
Deshmukh A, Oral E, Ghannam M, Liang J, Saeed M, Cunnane R, Ghanbari H, Latchamsetty R, Crawford T, Bogun F, Jongnarangsin K, Pelosi F, Chugh A, Morady F, Oral H
BPC-157 nasal spray dosing Standard injectable BPC-157 protocols typically use 200-500mcg administered subcutaneously once or twice daily
Case reports and small cohort studies describe women with endometriosis experiencing reduced pain and improved metabolic markers while on semaglutide or other GLP-1s prescribed for weight management or diabetes
If you are traveling internationally, check local regulations on injectable medications before departure, as some countries restrict GLP-1 compounds
Appointments are finished within 10 minutes and you are free to go on with your day